Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy

European Journal of Immunology

Volumn 31, Issue 12, 2001, Pages 3704-3713

  Nasser, S M Shuaib ^a   Ying, Sun ^b   Meng, Qiu ^b   Kay, A Barry ^b   Ewan, Pamela W ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Allergy; Cytokine; Eosinophil; Immunotherapy; Th1; Th2

Indexed keywords

ALLERGEN; CD68 ANTIGEN; ELASTASE; EOTAXIN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; RANTES; TRANSFORMING GROWTH FACTOR BETA; WASP VENOM;

ADULT; ANAPHYLAXIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; INSECT STING; LEUKOCYTE COUNT; MACROPHAGE; MALE; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; TH1 CELL; WASP;

ADULT; ALLERGENS; ANIMALS; BIOPSY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; IN SITU HYBRIDIZATION; INSECT BITES AND STINGS; INTERFERON TYPE II; INTERLEUKIN-10; MALE; MIDDLE AGED; RNA, MESSENGER; SKIN; WASP VENOMS;

EID: 0035666653     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200112)31:12<3704::AID-IMMU3704>3.0.CO;2-3     Document Type: Article

References (46)

1. Measurement of IgG-blocking antibodies: Development and application of a radioimmunoassay
2. Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy
3. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response
4. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses
5. Venom-specific IgG antibodies in bee and wasp allergy: Lack of correlation with protection from stings
6. A comparative study of IgG subclass antibodies in patients allergic to wasp or bee venom
7. The evaluation of the common diagnostic methods of hypersensitivity for bee and yellow jacket venom by means of an in-hospital insect sting
8. Provocation test with a living insect as a diagnostic tool in systemic reactions to bee and wasp venom: A prospective study with emphasis on the clinical aspects
9. Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom
10. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants
11. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells
12. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma
13. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures
14. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: Comparison of rush and conventional immunotherapy
15. Immune mechanisms in allergen-specific immunotherapy
16. Suppression of the late cutaneous response by immunotherapy
17. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses
18. Controlled trial of hyposensitisation to Dermatophagoides pteronyssinus in children with asthma
19. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment
20. Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus)
21. + T lyumphocytes: A process regulated by interleukin-10
22. Interleukin-10 inhibits interleukin-8 production in human neutrophils
23. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
24. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression
25. Interleukin 10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
26. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice
27. + T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity
28. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10
29. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation
30. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils
31. CD40 expression by human peripheral blood eosinophils
32. Induction of hapten-specific tolerance by interleukin 10 in vivo
33. Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice
34. Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects
35. IL-4 and IL-5-positive T lymphocytes, eosinophils and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects
36. Role of interleukin 10 in specific immunotherapy
37. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro
38. + T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma
39. Long-term clinical efficacy of grass-pollen immunotherapy
40. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
41. Insect venom immunotherapy induces interleukin-10 production and a Th2 to Th1 shift, and changes surface marker expression in venom-allergic subjects
42. Interleukin-10 regulation in normal subjects and patients with asthma
43. Immunohisto-chemistry on resin sections: A comparison of resin embedding techniques for small mucosal biopsies
44. + lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man
45. Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity
46. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: Association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES)